*Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasda... GlobeNewswire
Market data is delayed by at least 15 minutes.
    Latest Story
    Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
     GlobeNewswire
    Full Story →

    Headline News
    Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients
    7:00a ET April 18 '24 GlobeNewswire
    Bio-Path Holdings Expands Global Patent Portfolio
    7:00a ET April 15 '24 GlobeNewswire
    Bio-Path Holdings Provides 2024 Clinical and Operational Update
    7:00a ET April 2 '24 GlobeNewswire
    More News →
    Day  0.00%Week  37.7%Month  3.45%More Charting →
    Today, 10:16a ET Friday April 19 '24. Markets Open.
    Last $4.20
    Day change   0.00%$0.00
    Open $4.25
    Gap at open $0.05
    Previous close $4.20
    Trading volume 1,333,226
    10 Day avg vol. 9,390,139
    Shares out. 754.0K
    Market cap. $3.2Mil
    Trading activity Above Avg.
    Previous data from yesterday, April 18 '24.

    Historical Price Performance
    3 month   48.40% 
    6 month   69.46% 
    1 year   85.40% 
    2 year   92.88% 

    Earnings
    Previous 12m -$35.76
    Next 12m Estimate -$18.71
    P/E ratio 0.1x
    Revenue 0Mil

    Market data provided by News provided by